US20160229699A1 - Method of producing biogenic silica nanoparticles - Google Patents
Method of producing biogenic silica nanoparticles Download PDFInfo
- Publication number
- US20160229699A1 US20160229699A1 US14/617,537 US201514617537A US2016229699A1 US 20160229699 A1 US20160229699 A1 US 20160229699A1 US 201514617537 A US201514617537 A US 201514617537A US 2016229699 A1 US2016229699 A1 US 2016229699A1
- Authority
- US
- United States
- Prior art keywords
- silica nanoparticles
- seed hulls
- acid
- biogenic silica
- biogenic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 title claims abstract description 191
- 239000000377 silicon dioxide Substances 0.000 title claims abstract description 94
- 239000002105 nanoparticle Substances 0.000 title claims abstract description 81
- 230000000035 biogenic effect Effects 0.000 title claims abstract description 80
- 238000000034 method Methods 0.000 title claims abstract description 26
- 239000002253 acid Substances 0.000 claims abstract description 28
- 238000001354 calcination Methods 0.000 claims abstract description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 6
- 238000005406 washing Methods 0.000 claims abstract description 5
- 241000196324 Embryophyta Species 0.000 claims description 20
- 240000006394 Sorghum bicolor Species 0.000 claims description 20
- 244000115721 Pennisetum typhoides Species 0.000 claims description 19
- 235000007195 Pennisetum typhoides Nutrition 0.000 claims description 19
- 235000007230 Sorghum bicolor Nutrition 0.000 claims description 17
- 244000078127 Eleusine coracana Species 0.000 claims description 16
- 235000007349 Eleusine coracana Nutrition 0.000 claims description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims 2
- 238000010438 heat treatment Methods 0.000 claims 2
- 239000002245 particle Substances 0.000 abstract description 6
- 238000007605 air drying Methods 0.000 abstract description 3
- 238000003917 TEM image Methods 0.000 description 26
- 210000004027 cell Anatomy 0.000 description 13
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 10
- 239000010903 husk Substances 0.000 description 9
- 238000002441 X-ray diffraction Methods 0.000 description 7
- 239000002154 agricultural waste Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 238000003570 cell viability assay Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 235000008515 Setaria glauca Nutrition 0.000 description 3
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 3
- 244000062793 Sorghum vulgare Species 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- 235000019713 millet Nutrition 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000011031 large-scale manufacturing process Methods 0.000 description 2
- 239000002086 nanomaterial Substances 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 102000012422 Collagen Type I Human genes 0.000 description 1
- 108010022452 Collagen Type I Proteins 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 239000001692 EU approved anti-caking agent Substances 0.000 description 1
- 238000000134 MTT assay Methods 0.000 description 1
- 231100000002 MTT assay Toxicity 0.000 description 1
- 239000012901 Milli-Q water Substances 0.000 description 1
- 102000008108 Osteoprotegerin Human genes 0.000 description 1
- 108010035042 Osteoprotegerin Proteins 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 241000209046 Pennisetum Species 0.000 description 1
- 239000006004 Quartz sand Substances 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 230000036579 abiotic stress Effects 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000012271 agricultural production Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000004790 biotic stress Effects 0.000 description 1
- 239000012888 bovine serum Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000005049 combustion synthesis Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 238000001027 hydrothermal synthesis Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 238000002354 inductively-coupled plasma atomic emission spectroscopy Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000012212 insulator Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 238000000593 microemulsion method Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- 239000002114 nanocomposite Substances 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- XXUPLYBCNPLTIW-UHFFFAOYSA-N octadec-7-ynoic acid Chemical compound CCCCCCCCCCC#CCCCCCC(O)=O XXUPLYBCNPLTIW-UHFFFAOYSA-N 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 230000004072 osteoblast differentiation Effects 0.000 description 1
- 210000002997 osteoclast Anatomy 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000000634 powder X-ray diffraction Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 238000003980 solgel method Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B33/00—Silicon; Compounds thereof
- C01B33/113—Silicon oxides; Hydrates thereof
- C01B33/12—Silica; Hydrates thereof, e.g. lepidoic silicic acid
- C01B33/18—Preparation of finely divided silica neither in sol nor in gel form; After-treatment thereof
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B33/00—Silicon; Compounds thereof
- C01B33/113—Silicon oxides; Hydrates thereof
- C01B33/12—Silica; Hydrates thereof, e.g. lepidoic silicic acid
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B33/00—Silicon; Compounds thereof
- C01B33/113—Silicon oxides; Hydrates thereof
- C01B33/12—Silica; Hydrates thereof, e.g. lepidoic silicic acid
- C01B33/126—Preparation of silica of undetermined type
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/60—Particles characterised by their size
- C01P2004/64—Nanometer sized, i.e. from 1-100 nanometer
Definitions
- the present invention relates to agri-nanotechnology, and particularly to a method of preparing biogenic silica nanoparticles from the seed hulls of various plants.
- Nanomaterials defined as particles with a size of less than 100 nm, have been useful in various industries, including, electrical, textile, medicine, cosmetics, agriculture and food. Nanomaterials have unique physiochemical properties. Silica is the second most abundant element on earth. Silica nanoparticles (SiO 2 -NPs) have been used in various applications including catalysis, pigments, thin film substrates, thermal insulators, pesticides, food additives, drug delivery, gene therapy, molecular imaging and additives in plastics. Silica plays an important physiological role in plants; as an alleviator of biotic and abiotic stress. Silicon supplement diets have increased the bone mineral density in women, increased type I collagen synthesis, and induced osteoblast differentiation.
- Biosilica is a selective inducer of osteoprotegerin expression resulting in inactivation of osteoclast differentiation.
- Silica inhibits the aluminum uptake in the gastrointestinal tract due to the interaction between aluminum and silica.
- Silica nanoparticles (SiO 2 -NPs) are used in numerous applications and, as a consequence, large quantities are required. Thus, there is a need to develop an easy and economical method to produce SiO 2 -NPs.
- FIG. 1A shows an X-ray Diffraction (XRD) pattern of biogenic silica nanoparticles prepared from Elucine corcana using calcination temperatures of 500° C., 600° C., and 700° C.
- XRD X-ray Diffraction
- FIG. 1B shows an X-ray Diffraction (XRD) pattern of biogenic silica nanoparticles prepared from Sorghum bicolor using calcination temperatures of 500° C., 600° C., and 700° C.
- XRD X-ray Diffraction
- FIG. 1C shows an X-ray Diffraction (XRD) pattern of biogenic silica nanoparticles prepared from Pennisetum glaucum using calcination temperatures of 500° C., 600° C., and 700° C.
- XRD X-ray Diffraction
- FIG. 2A shows the Transmission Electron Micrograph (TEM) image of the biogenic silica nanoparticles prepared from Eleusine coracana husk using a calcination temperature of 500° C.
- TEM Transmission Electron Micrograph
- FIG. 2B shows the Transmission Electron Micrograph (TEM) image of the biogenic silica nanoparticles prepared from Eleusine coracana husk using a calcination temperature of 600° C.
- TEM Transmission Electron Micrograph
- FIG. 2C shows the Transmission Electron Micrograph (TEM) image of the biogenic silica nanoparticles prepared from Eleusine coracana husk using a calcination temperature of 700° C.
- TEM Transmission Electron Micrograph
- FIG. 3A shows the Transmission Electron Micrograph (TEM) image of the biogenic silica nanoparticles prepared from Sorghum bicolor husk using a calcination temperature of 500° C.
- TEM Transmission Electron Micrograph
- FIG. 3B shows the Transmission Electron Micrograph (TEM) image of the biogenic silica nanoparticles prepared from Sorghum bicolor husk using a calcination temperature of 600° C.
- TEM Transmission Electron Micrograph
- FIG. 3C shows the Transmission Electron Micrograph (TEM) image of the biogenic silica nanoparticles prepared from Sorghum bicolor husk using a calcination temperature of 700° C.
- FIG. 4A shows the Transmission Electron Micrograph (TEM) image of the biogenic silica nanoparticles prepared from Pennisetum glaucum husk using a calcination temperature of 500° C.
- TEM Transmission Electron Micrograph
- FIG. 4B shows the Transmission Electron Micrograph (TEM) image of the biogenic silica nanoparticles prepared from Pennisetum glaucum husk using a calcination temperature of 600° C.
- TEM Transmission Electron Micrograph
- FIG. 4C shows the Transmission Electron Micrograph (TEM) image of the biogenic silica nanoparticles prepared from Pennisetum glaucum husk using a calcination temperature of 700° C.
- TEM Transmission Electron Micrograph
- FIG. 5A shows a graph of results of the cell viability assay of human mesenchymal stem cells treated with biogenic silica nanoparticles prepared using Eleusine coracana .
- FIG. 5B shows a graph of results of the cell viability assay of human mesenchymal stem cells treated with biogenic silica nanoparticles prepared using Sorghum bicolor .
- FIG. 5C shows a graph of results of the cell viability assay of human mesenchymal stem cells treated with biogenic silica nanoparticles prepared using Pennisetum glaucum .
- FIG. 6 shows the nuclear morphology of human mesenchymal stem cells treated with Eleusine coracana biogenic silica nanoparticles prepared using a calcination temperature of 700° C.
- FIG. 7 shows the nuclear morphology of human mesenchymal stem cells treated with Sorghum bicolor biogenic silica nanoparticles prepared using a calcination temperature of 700° C.
- FIG. 8 shows the nuclear morphology of human mesenchymal stem cells treated with Pennisetum glaucum biogenic silica nanoparticles prepared using a calcination temperature of 700° C.
- a method of producing biogenic silica nanoparticles includes pretreating seed hulls of a plant with an acid to form acid-treated seed hulls, placing the acid-treated seed hulls in an autoclave at a temperature greater than 100° C. for about 2 hours under pressurized conditions, isolating the seed hulls, washing the seed hulls with water, air drying the seed hulls, calcining the seed hulls at a temperature range of about 500° C. to about 700° C. for at least one hour in a furnace to produce biogenic silica nanoparticles.
- the plant can be millet ( Eleusine coracana ), sorghum ( Sorghum bicolor ), and pearl millet ( Pennisetum glaucum ).
- the biogenic silica nanoparticles are amorphous and biocompatible. The biogenic silica nanoparticles range from about 20 nm to about 75 nm in size.
- a method of producing biogenic silica nanoparticles includes pretreating seed hulls of a plant with an acid to form a mixture, placing the mixture in an autoclave at a temperature greater than 100° C. for about 2 hours under pressurized conditions, isolating the seed hulls, washing the seed hulls with water; air drying said seed hulls, calcining the seed hulls at a temperature range of about 500° C. to about 700° C. for at least one hour in a furnace to obtain biogenic silica nanoparticles.
- the plant can be millet ( Eleusine coracana ), sorghum ( Sorghum bicolor ), and pearl millet ( Pennisetum glaucum ).
- the biogenic silica nanoparticles are amorphous and biocompatible. The biogenic silica nanoparticles range from about 20 nm to about 75 nm in size.
- Millet Eleusine coracana
- sorghum Sorghum bicolor
- pearl millet Pennisetum glaucum
- the seed hulls of these plants contain approximately 5-15% of silica, 80-85% of organic materials and traceable quantity of metal ions.
- the hulls are the natural shells or sheaths that form the outer covering of the grains, which are the seeds. They are removed during the refining process and remain as low value by-product and agricultural waste.
- the hulls of the plant seeds can be ground and sieved. Then, as mentioned above, the hulls can be treated with an acid to form an acid-treated mixture.
- the acid can be, for example, 1 N hydrochloric acid.
- the acid-treated mixture can be heated at a temperature greater than 100° C. For example, the acid-treated mixture can be transferred to an autoclave and maintained at 120° C. for about 2 hours under pressurized conditions, e.g. 15 lbs.
- the elemental profile results of the biogenic silica nanoparticles produced in accordance with the present method indicated a purity of 99.53%.
- the biogenic silica nanoparticles produced according to the present method are amorphous and range in size from about 25 nm to about 75 nm.
- the biogenic silica nanoparticles produced according to the present method are non-toxic and bio compatible with human mesenchymal stem cells (hMSc).
- hMSc human mesenchymal stem cells
- biogenic silica nanoparticles produced according to the present methods can be useful in nutraceutical and dietary supplements, bone tissue engineering, anti-caking agents, excipients associated with the food industry, catalysts, water treatment and in other biomedical applications.
- the selected plant seed hulls or bio-precursors described herein can be used for synthesis of various materials including silica nano-composites and zeolites. The following examples will further illustrate the invention but are not to be construed as limiting its scope.
- the seed hulls of Eleusine coracana, Sorghum bicolor , and Pennisetum glaucum were collected from a post-harvesting mill, in Karur, Tamil Nadu (India). The collected materials were ground and sieved using 18 mesh size for further studies. Total silica content of plant's seed hulls was quantified adopting AOAC procedures.
- hMSc Human mesenchymal stem cells
- biogenic silica nanoparticles were investigated using powder XRD (JEOL model).
- the prepared biogenic silica powders were dispersed in pure ethanol and ultrasonicated before transmission electron micrograph (TEM) characterization.
- the morphologies and sizes of the samples were examined using a JEOL transmission electron microscope (TEM) at an accelerating voltage of 200 kV.
- TEM JEOL transmission electron microscope
- FIG. 1A shows the XRD pattern of the biogenic silica nanoparticles derived from Eleusine coracana plant seed hulls. Broad XRD peaks can be seen in FIG. 1A , with a 2 ⁇ value between 15-35° , which indicates that the formed silica nanoparticles are amorphous.
- FIGS. 1B and 1C show the XRD pattern of biogenic silica nanoparticles derived from Sorghum bicolor and Pennisetum glaucum , respectively. The results show broad XRD peaks corresponding to amorphous silica nanoparticles. The broadness of the XRD peaks confirms that the prepared biogenic silica is nanoscale in size.
- FIGS. 2A-2C show the TEM images of the biogenic silica nanoparticles derived from Eleusine coracana using calcination temperatures of 500° C. ( FIG. 2A ), 600° C. ( FIG. 2B ), and 700° C. ( FIG. 2C ).
- the biogenic silica nanoparticles are spherical and about 25-75 nm in size, but the particles are aggregated.
- FIGS. 3A-3C show the TEM images of the prepared biogenic silica nanoparticles from Sorghum bicolor using calcination temperatures of 500° C. ( FIG. 3A ), 600° C. ( FIG.
- FIGS. 4A-4C show the TEM images of the Pennisetum glaucum biogenic silica using calcination temperatures of 500° C. ( FIG. 4A ), 600° C. ( FIG. 4B ), and 700° C. ( FIG. 4C ).
- the TEM images confirmed that the prepared particles were about 40-60 nm, and spherical in shape. However, the particle size and shape varied based on their bio-precursor and calcination temperatures.
- the purity of the prepared biogenic silica was analyzed using ICP-OES. The results suggested that prepared samples are highly pure (Table 1).
- the biocompatibility of the prepared biogenic silica nanoparticles were assessed by an MTT assay.
- the hMSc were seeded at a density of 1 ⁇ 10 4 cells per well in 200 ⁇ L of fresh culture medium and incubated overnight at 37 ° C. and 5% CO 2 . After overnight growth, the cells were treated with different concentrations (25-400 ng/mL) of well characterized biogenic silica nanoparticles for 24 and 48 h. After incubation, 20 ⁇ L of MTT solution [5 mg/mL in phosphate-buffered saline (PBS)] was added to each well. The plates were wrapped with aluminum foil and incubated for 4 h at 37° C.
- PBS phosphate-buffered saline
- the plates were centrifuged, and the purple formazan product was dissolved by the addition of 100 ⁇ L of DMSO to each well.
- the absorbance was monitored at 570 nm (measurement) and 630 nm (reference) using a 96-well plate reader (Bio-Rad, CA, USA). Data were collected for tetraplicates of each biogenic silica nanoparticles concentration, and these data were used to calculate the mean. The percent inhibition was calculated from these data by the following formula:
- Cell ⁇ ⁇ viability Mean ⁇ ⁇ OD ⁇ ⁇ of ⁇ ⁇ untreated ⁇ ⁇ cells ⁇ ⁇ ( control ) - Mean ⁇ ⁇ OD ⁇ ⁇ of ⁇ ⁇ treated ⁇ ⁇ cells ⁇ 100 Mean ⁇ ⁇ OD ⁇ ⁇ of ⁇ ⁇ untreated ⁇ ⁇ cells ⁇ ⁇ ( control )
- FIGS. 5A-5C shows results of the cell viability assay of human mesenchymal stem cells (hMSC) treated with biogenic silica nanoparticles prepared using (a) Eleusine coracana ( FIG. 5A ), (b) Sorghum bicolor ( FIG. 5B ), and (c) Pennisetum glaucum ( FIG. 5C ).
- the hMSC were exposed to various concentrations (25, 50, 100, 200 and 400 ⁇ g/mL) of biogenic silica nanoparticles derived from various plant seed hulls for 24 hours. Ultimately, there was no difference between the control and the low concentration group, whereas slight changes were observed at the high concentration. Because the cell viability was greater than 95% at the high concentrations, the results indicate that prepared biogenic silica nanoparticles exhibited biocompatibility with hMSCs.
- the nuclear and cytoplasmic morphology of the hMSc cells were analyzed after treatment with biogenic silica nanoparticles for 24 and 48 hours. Control cells were grown in the same manner in the absence of biogenic silica nanoparticles. The cells were trypsinized and fixed with methanol. The cell nuclei were then stained by treatment with 1 mg/mL propidium iodide (Sigma) at 37° C. for 15 min in the dark. The stained cells were examined under an inverted fluorescence microscope (Carl Zeiss, Jena, Germany). The results are presented as a series of triplicates.
- FIGS. 6, 7 and 8 show the nuclear morphology of human mesenchymal stem cells (hMSC) treated with biogenic silica nanoparticles derived at 700° C. from seed hulls of Eleusine coracana ( FIG. 6 ), Sorghum bicolor ( FIG. 7 ) and Pennisetum glaucum ( FIG. 8 ) respectively.
- the observations confirmed that the biogenic silica nanoparticles are non-toxic and biocompatible with hMSCs.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Silicon Compounds (AREA)
Abstract
Description
- 1. Field of the Invention
- The present invention relates to agri-nanotechnology, and particularly to a method of preparing biogenic silica nanoparticles from the seed hulls of various plants.
- 2. Description of the Related Art
- Nanomaterials, defined as particles with a size of less than 100 nm, have been useful in various industries, including, electrical, textile, medicine, cosmetics, agriculture and food. Nanomaterials have unique physiochemical properties. Silica is the second most abundant element on earth. Silica nanoparticles (SiO2-NPs) have been used in various applications including catalysis, pigments, thin film substrates, thermal insulators, pesticides, food additives, drug delivery, gene therapy, molecular imaging and additives in plastics. Silica plays an important physiological role in plants; as an alleviator of biotic and abiotic stress. Silicon supplement diets have increased the bone mineral density in women, increased type I collagen synthesis, and induced osteoblast differentiation.
- Biosilica is a selective inducer of osteoprotegerin expression resulting in inactivation of osteoclast differentiation. Silica inhibits the aluminum uptake in the gastrointestinal tract due to the interaction between aluminum and silica.
- Silica nanoparticles (SiO2-NPs) are used in numerous applications and, as a consequence, large quantities are required. Thus, there is a need to develop an easy and economical method to produce SiO2-NPs.
- A variety of methods have been used for preparing silica nanoparticles namely, microwave hydrothermal process, flame synthesis, sol-gel process, micro-emulsion method, and combustion synthesis. In large scale production of silica, quartz sand is treated with sodium carbonate at 1300° C. This method is hazardous to the environment because it emits a large quantity of CO2 gas. Moreover, presently there is a major problem in sustainability due to the generation of a large quantity of agricultural waste. It has been estimated that 140 billion metric tons of agricultural waste is generated every year worldwide due to agricultural production and processing. However, huge quantity of agricultural waste management is difficult and represents a major challenge. The improper usage of agricultural wastes creates an ecological contamination. Therefore, it would be desirable to convert agricultural waste to valuable products in an efficient way for industrial use.
- Thus, a method of producing biogenic silica nanoparticles from the bio-precursors of cultivated plants solving the aforementioned problems is desired.
-
FIG. 1A shows an X-ray Diffraction (XRD) pattern of biogenic silica nanoparticles prepared from Elucine corcana using calcination temperatures of 500° C., 600° C., and 700° C. -
FIG. 1B shows an X-ray Diffraction (XRD) pattern of biogenic silica nanoparticles prepared from Sorghum bicolor using calcination temperatures of 500° C., 600° C., and 700° C. -
FIG. 1C shows an X-ray Diffraction (XRD) pattern of biogenic silica nanoparticles prepared from Pennisetum glaucum using calcination temperatures of 500° C., 600° C., and 700° C. -
FIG. 2A shows the Transmission Electron Micrograph (TEM) image of the biogenic silica nanoparticles prepared from Eleusine coracana husk using a calcination temperature of 500° C. -
FIG. 2B shows the Transmission Electron Micrograph (TEM) image of the biogenic silica nanoparticles prepared from Eleusine coracana husk using a calcination temperature of 600° C. -
FIG. 2C shows the Transmission Electron Micrograph (TEM) image of the biogenic silica nanoparticles prepared from Eleusine coracana husk using a calcination temperature of 700° C. -
FIG. 3A shows the Transmission Electron Micrograph (TEM) image of the biogenic silica nanoparticles prepared from Sorghum bicolor husk using a calcination temperature of 500° C. -
FIG. 3B shows the Transmission Electron Micrograph (TEM) image of the biogenic silica nanoparticles prepared from Sorghum bicolor husk using a calcination temperature of 600° C. -
FIG. 3C shows the Transmission Electron Micrograph (TEM) image of the biogenic silica nanoparticles prepared from Sorghum bicolor husk using a calcination temperature of 700° C. -
FIG. 4A shows the Transmission Electron Micrograph (TEM) image of the biogenic silica nanoparticles prepared from Pennisetum glaucum husk using a calcination temperature of 500° C. -
FIG. 4B shows the Transmission Electron Micrograph (TEM) image of the biogenic silica nanoparticles prepared from Pennisetum glaucum husk using a calcination temperature of 600° C. -
FIG. 4C shows the Transmission Electron Micrograph (TEM) image of the biogenic silica nanoparticles prepared from Pennisetum glaucum husk using a calcination temperature of 700° C. -
FIG. 5A shows a graph of results of the cell viability assay of human mesenchymal stem cells treated with biogenic silica nanoparticles prepared using Eleusine coracana. -
FIG. 5B shows a graph of results of the cell viability assay of human mesenchymal stem cells treated with biogenic silica nanoparticles prepared using Sorghum bicolor. -
FIG. 5C shows a graph of results of the cell viability assay of human mesenchymal stem cells treated with biogenic silica nanoparticles prepared using Pennisetum glaucum. -
FIG. 6 shows the nuclear morphology of human mesenchymal stem cells treated with Eleusine coracana biogenic silica nanoparticles prepared using a calcination temperature of 700° C. -
FIG. 7 shows the nuclear morphology of human mesenchymal stem cells treated with Sorghum bicolor biogenic silica nanoparticles prepared using a calcination temperature of 700° C. -
FIG. 8 shows the nuclear morphology of human mesenchymal stem cells treated with Pennisetum glaucum biogenic silica nanoparticles prepared using a calcination temperature of 700° C. - Similar reference characters denote corresponding features consistently throughout the attached drawings.
- A method of producing biogenic silica nanoparticles includes pretreating seed hulls of a plant with an acid to form acid-treated seed hulls, placing the acid-treated seed hulls in an autoclave at a temperature greater than 100° C. for about 2 hours under pressurized conditions, isolating the seed hulls, washing the seed hulls with water, air drying the seed hulls, calcining the seed hulls at a temperature range of about 500° C. to about 700° C. for at least one hour in a furnace to produce biogenic silica nanoparticles. The plant can be millet (Eleusine coracana), sorghum (Sorghum bicolor), and pearl millet (Pennisetum glaucum). The biogenic silica nanoparticles are amorphous and biocompatible. The biogenic silica nanoparticles range from about 20 nm to about 75 nm in size.
- A method of producing biogenic silica nanoparticles includes pretreating seed hulls of a plant with an acid to form a mixture, placing the mixture in an autoclave at a temperature greater than 100° C. for about 2 hours under pressurized conditions, isolating the seed hulls, washing the seed hulls with water; air drying said seed hulls, calcining the seed hulls at a temperature range of about 500° C. to about 700° C. for at least one hour in a furnace to obtain biogenic silica nanoparticles. The plant can be millet (Eleusine coracana), sorghum (Sorghum bicolor), and pearl millet (Pennisetum glaucum). The biogenic silica nanoparticles are amorphous and biocompatible. The biogenic silica nanoparticles range from about 20 nm to about 75 nm in size.
- Millet, (Eleusine coracana), sorghum (Sorghum bicolor), and pearl millet (Pennisetum glaucum) are important traditional crops in Saudi Arabia and elsewhere. The seed hulls of these plants contain approximately 5-15% of silica, 80-85% of organic materials and traceable quantity of metal ions. The hulls are the natural shells or sheaths that form the outer covering of the grains, which are the seeds. They are removed during the refining process and remain as low value by-product and agricultural waste.
- The hulls of the plant seeds can be ground and sieved. Then, as mentioned above, the hulls can be treated with an acid to form an acid-treated mixture. The acid can be, for example, 1 N hydrochloric acid. The acid-treated mixture can be heated at a temperature greater than 100° C. For example, the acid-treated mixture can be transferred to an autoclave and maintained at 120° C. for about 2 hours under pressurized conditions, e.g. 15 lbs.
- The elemental profile results of the biogenic silica nanoparticles produced in accordance with the present method indicated a purity of 99.53%. The biogenic silica nanoparticles produced according to the present method are amorphous and range in size from about 25 nm to about 75 nm. The biogenic silica nanoparticles produced according to the present method are non-toxic and bio compatible with human mesenchymal stem cells (hMSc). The present method for providing biogenic silica nanoparticles is simple, cost-effective, and well-suited for large scale production. Accordingly, the biogenic silica nanoparticles produced according to the present methods can be useful in nutraceutical and dietary supplements, bone tissue engineering, anti-caking agents, excipients associated with the food industry, catalysts, water treatment and in other biomedical applications. The selected plant seed hulls or bio-precursors described herein can be used for synthesis of various materials including silica nano-composites and zeolites. The following examples will further illustrate the invention but are not to be construed as limiting its scope.
- The seed hulls of Eleusine coracana, Sorghum bicolor, and Pennisetum glaucum were collected from a post-harvesting mill, in Karur, Tamil Nadu (India). The collected materials were ground and sieved using 18 mesh size for further studies. Total silica content of plant's seed hulls was quantified adopting AOAC procedures.
- Human mesenchymal stem cells (hMSc) were obtained from Thermo Scientific Hyclone (USA). The cells were cultured in DMEM medium supplemented with 10% bovine serum, 100 μg/mL of penicillin and 100 μg/mL of streptomycin in 96-well culture plates at 37° C. in a humidified atmosphere containing 5% CO2. All experiments were performed with cells from 15 passages or less.
- Approximately 100 grams of the selected seed hulls were mixed with 500 ml of 1 N HC1 in separate conical flasks. These mixtures were transferred to an autoclave and maintained at 120° C. for 2 hours under pressurized (15 lb) conditions. The acid-pretreated plant's seed hulls was isolated and washed with Milli-Q water to remove the hydrochloric acid. Residue from the acid-pretreated seed hulls were dried and subsequently calcinated at temperatures of 500° C., 600° C., and 700° C. for 1 hour using a muffle furnace.
- The crystalline nature of the obtained biogenic silica nanoparticles were investigated using powder XRD (JEOL model). The prepared biogenic silica powders were dispersed in pure ethanol and ultrasonicated before transmission electron micrograph (TEM) characterization. The morphologies and sizes of the samples were examined using a JEOL transmission electron microscope (TEM) at an accelerating voltage of 200 kV. Biogenic silica samples derived at 700° C. were used for analysis of biological properties.
-
FIG. 1A shows the XRD pattern of the biogenic silica nanoparticles derived from Eleusine coracana plant seed hulls. Broad XRD peaks can be seen inFIG. 1A , with a 2θ value between 15-35° , which indicates that the formed silica nanoparticles are amorphous.FIGS. 1B and 1C show the XRD pattern of biogenic silica nanoparticles derived from Sorghum bicolor and Pennisetum glaucum, respectively. The results show broad XRD peaks corresponding to amorphous silica nanoparticles. The broadness of the XRD peaks confirms that the prepared biogenic silica is nanoscale in size. - The size and morphology of the prepared biogenic silica nanoparticles were analyzed using transmission electron microscope (TEM).
FIGS. 2A-2C show the TEM images of the biogenic silica nanoparticles derived from Eleusine coracana using calcination temperatures of 500° C. (FIG. 2A ), 600° C. (FIG. 2B ), and 700° C. (FIG. 2C ). The biogenic silica nanoparticles are spherical and about 25-75 nm in size, but the particles are aggregated.FIGS. 3A-3C show the TEM images of the prepared biogenic silica nanoparticles from Sorghum bicolor using calcination temperatures of 500° C. (FIG. 3A ), 600° C. (FIG. 3B ), and 700° C. (FIG. 3C ). The indicate silica nanoparticles are 20-60 nm in size and aggregated. It was discovered that when the calcination temperature increased, the particle size also increased. This result suggests that calcination temperature plays a vital role in biogenic silica nanoparticles formation.FIGS. 4A-4C show the TEM images of the Pennisetum glaucum biogenic silica using calcination temperatures of 500° C. (FIG. 4A ), 600° C. (FIG. 4B ), and 700° C. (FIG. 4C ). The TEM images confirmed that the prepared particles were about 40-60 nm, and spherical in shape. However, the particle size and shape varied based on their bio-precursor and calcination temperatures. The purity of the prepared biogenic silica was analyzed using ICP-OES. The results suggested that prepared samples are highly pure (Table 1). -
TABLE 1 Biogenic Silica Nanoparticles prepared from seed hulls of various plant materials. Silica in seed Calcination Biogenic silica Plants hulls (%) temperature nanoparticles (%) Eleusine coracana 6.8 500° C. 99.123 600° C. 99.28 700° C. 99.54 Sorghum bicolor 7.8 500° C. 98.933 600° C. 98.97 700° C. 99.32 Pennisetum 6.1 500° C. 99.53 glaucum 600° C. 99.58 700° C. 99.64 - The biocompatibility of the prepared biogenic silica nanoparticles were assessed by an MTT assay. The hMSc were seeded at a density of 1×104 cells per well in 200 μL of fresh culture medium and incubated overnight at 37 ° C. and 5% CO2. After overnight growth, the cells were treated with different concentrations (25-400 ng/mL) of well characterized biogenic silica nanoparticles for 24 and 48 h. After incubation, 20 μL of MTT solution [5 mg/mL in phosphate-buffered saline (PBS)] was added to each well. The plates were wrapped with aluminum foil and incubated for 4 h at 37° C. The plates were centrifuged, and the purple formazan product was dissolved by the addition of 100 μL of DMSO to each well. The absorbance was monitored at 570 nm (measurement) and 630 nm (reference) using a 96-well plate reader (Bio-Rad, CA, USA). Data were collected for tetraplicates of each biogenic silica nanoparticles concentration, and these data were used to calculate the mean. The percent inhibition was calculated from these data by the following formula:
-
-
FIGS. 5A-5C shows results of the cell viability assay of human mesenchymal stem cells (hMSC) treated with biogenic silica nanoparticles prepared using (a) Eleusine coracana (FIG. 5A ), (b) Sorghum bicolor (FIG. 5B ), and (c) Pennisetum glaucum (FIG. 5C ). The hMSC were exposed to various concentrations (25, 50, 100, 200 and 400 μg/mL) of biogenic silica nanoparticles derived from various plant seed hulls for 24 hours. Ultimately, there was no difference between the control and the low concentration group, whereas slight changes were observed at the high concentration. Because the cell viability was greater than 95% at the high concentrations, the results indicate that prepared biogenic silica nanoparticles exhibited biocompatibility with hMSCs. - The nuclear and cytoplasmic morphology of the hMSc cells were analyzed after treatment with biogenic silica nanoparticles for 24 and 48 hours. Control cells were grown in the same manner in the absence of biogenic silica nanoparticles. The cells were trypsinized and fixed with methanol. The cell nuclei were then stained by treatment with 1 mg/mL propidium iodide (Sigma) at 37° C. for 15 min in the dark. The stained cells were examined under an inverted fluorescence microscope (Carl Zeiss, Jena, Germany). The results are presented as a series of triplicates.
-
FIGS. 6, 7 and 8 show the nuclear morphology of human mesenchymal stem cells (hMSC) treated with biogenic silica nanoparticles derived at 700° C. from seed hulls of Eleusine coracana (FIG. 6 ), Sorghum bicolor (FIG. 7 ) and Pennisetum glaucum (FIG. 8 ) respectively. The images revealed the presence of healthy, round nuclei cells, without any significant changes in cell morphology upon treatment of the hMSCs with the biogenic silica nanoparticles, where Dose-1=50 μg/mL and Dose-2=200 μg/mL for 24 and 48 hours. The observations confirmed that the biogenic silica nanoparticles are non-toxic and biocompatible with hMSCs. - It is to be understood that the present invention is not limited to the embodiments described above, but encompasses any and all embodiments within the scope of the following claims.
Claims (9)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/617,537 US9403688B1 (en) | 2015-02-09 | 2015-02-09 | Method of producing biogenic silica nanoparticles |
SA116370274A SA116370274B1 (en) | 2015-02-09 | 2016-02-04 | Method of producing biogenic silica nanoparticles |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/617,537 US9403688B1 (en) | 2015-02-09 | 2015-02-09 | Method of producing biogenic silica nanoparticles |
Publications (2)
Publication Number | Publication Date |
---|---|
US9403688B1 US9403688B1 (en) | 2016-08-02 |
US20160229699A1 true US20160229699A1 (en) | 2016-08-11 |
Family
ID=56507191
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/617,537 Active 2035-02-15 US9403688B1 (en) | 2015-02-09 | 2015-02-09 | Method of producing biogenic silica nanoparticles |
Country Status (2)
Country | Link |
---|---|
US (1) | US9403688B1 (en) |
SA (1) | SA116370274B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10384945B1 (en) | 2019-02-08 | 2019-08-20 | King Saud University | Method of producing silica nanoparticles using sand |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3281914B1 (en) * | 2016-08-11 | 2023-03-01 | Partchem GmbH | Method for producing highly dispersed surface-rich silicon dioxide from plants |
WO2020005091A1 (en) | 2018-06-28 | 2020-01-02 | Нина Андреевна Чернявская | Method for producing silicon dioxide |
RO133904B1 (en) | 2018-08-28 | 2023-11-29 | Institutul Naţional De Cercetare Dezvoltare Pentru Chimie Şi Petrochimie - Icechim Bucureşti | Process for preparing stable suspensions of silica and selenium nanoparticles |
US10383976B1 (en) | 2018-10-08 | 2019-08-20 | King Saud University | Method of fabricating nanostructures from fish waste |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5503931A (en) * | 1993-05-10 | 1996-04-02 | Goodman, Sr.; Elstun F. | Moisture absorbing material and methods of production |
WO2007026680A1 (en) * | 2005-08-31 | 2007-03-08 | Kurimoto, Ltd. | Amorphous silicon oxide powder and method for production thereof |
AU2007281404B2 (en) | 2006-08-02 | 2013-08-01 | Neal A. Hammond | Biogenic silica from silica-containing plant material such as rice hulls |
GB201103274D0 (en) * | 2011-02-25 | 2011-04-13 | Intrinsiq Materials Global Ltd | Mesoporous silicon |
-
2015
- 2015-02-09 US US14/617,537 patent/US9403688B1/en active Active
-
2016
- 2016-02-04 SA SA116370274A patent/SA116370274B1/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10384945B1 (en) | 2019-02-08 | 2019-08-20 | King Saud University | Method of producing silica nanoparticles using sand |
Also Published As
Publication number | Publication date |
---|---|
SA116370274B1 (en) | 2017-07-20 |
US9403688B1 (en) | 2016-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9403688B1 (en) | Method of producing biogenic silica nanoparticles | |
Kalaiselvi et al. | Microwave assisted green synthesis of Hydroxyapatite nanorods using Moringa oleifera flower extract and its antimicrobial applications | |
Velsankar et al. | Effect of cytotoxicity and aAntibacterial activity of biosynthesis of ZnO hexagonal shaped nanoparticles by Echinochloa frumentacea grains extract as a reducing agent | |
Alshatwi et al. | Biocompatibility assessment of rice husk-derived biogenic silica nanoparticles for biomedical applications | |
Shebl et al. | Template-free microwave-assisted hydrothermal synthesis of manganese zinc ferrite as a nanofertilizer for squash plant (Cucurbita pepo L) | |
Barakat et al. | Extraction of pure natural hydroxyapatite from the bovine bones bio waste by three different methods | |
Gopikrishnan et al. | Synthesis, characterization and biocompatibility studies of zinc oxide (ZnO) nanorods for biomedical application | |
Wu et al. | A hydrothermal synthesis of eggshell and fruit waste extract to produce nanosized hydroxyapatite | |
Shen et al. | Synthesis of strontium substituted hydroxyapatite whiskers used as bioactive and mechanical reinforcement material | |
Saha et al. | Influence of the various synthesis methods on the ZnO nanoparticles property made using the bark extract of Terminalia arjuna | |
Mahmoodzadeh et al. | Effect on germination and early growth characteristics in wheat plants (Triticumaestivum L.) seeds exposed to TiO2 nanoparticles | |
Wijesinghe et al. | Urea-assisted synthesis of hydroxyapatite nanorods from naturally occurring impure apatite rocks for biomedical applications | |
Guha et al. | Mesenchymal cell response to nanosized biphasic calcium phosphate composites | |
Yusoff et al. | Physicochemical, antibacterial and biocompatibility assessments of silver incorporated nano-hydroxyapatite synthesized using a novel microwave-assisted wet precipitation technique | |
Umesh et al. | Eggshells biowaste for hydroxyapatite green synthesis using extract piper betel leaf-Evaluation of antibacterial and antibiofilm activity | |
Modolon et al. | Nanostructured biological hydroxyapatite from Tilapia bone: A pathway to control crystallite size and crystallinity | |
Jayakodi et al. | Green synthesis of CuO nanoparticles and its application on toxicology evaluation | |
Nasim et al. | Green synthesis of reduced graphene oxide nanoparticles, its characterization and antimicrobial properties against common oral pathogens | |
Al-Enazi et al. | In vitro anticancer and antibacterial performance of biosynthesized Ag and Ce co-doped ZnO NPs | |
Aydin et al. | Production, characterization, and cytotoxicity of calcium phosphate ceramics derived from the bone of meagre fish, Argyrosomus regius | |
Abbasifar et al. | Antibacterial activity of silver nanoparticles synthesized by using extracts of Hedera helix | |
Kavaz | Synthesis of silica nanoparticles from agricultural waste | |
Ibrahim et al. | Potential of nanosilicon dioxide extraction from silicon-rich agriculture wastes as a plant growth promoter | |
Alshemary et al. | Bactericidal and in vitro osteogenic activity of nano sized cobalt-doped silicate hydroxyapatite | |
Hussin et al. | Characterization and in vitro evaluation of hydroxyapatite from Fringescale sardinella bones for biomedical applications |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: KING SAUD UNIVERSITY, SAUDI ARABIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ALSHATWI, ALI ABDULLAH, DR.;ATHINARAYANAN, JEGAN, MR.;PERIASAMY, VAIYAPURI SUBBARAYAN, DR.;REEL/FRAME:034922/0127 Effective date: 20141216 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2551); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY Year of fee payment: 4 |
|
FEPP | Fee payment procedure |
Free format text: MAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |